Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 101-125 of 671 matching filings.

Per page
25
Current page
5
DEF 14A File 001-33357

DEF 14A

Filing date
18 May 2023
Reporting date
28 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33357

PRE 14A

Filing date
02 May 2023
Reporting date
02 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-264394

424B5

Filing date
27 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A

Filing date
03 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Sep 2022
Reporting date
07 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Sep 2022
Reporting date
07 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Sep 2022
Reporting date
07 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Sep 2022
Reporting date
07 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Sep 2022
Reporting date
07 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .